The global computer aided detection (CAD) market size is expected to reach USD 1579.5 million in 2028 and register a CAGR of 10.9% according to the latest report by Reports and Data. Growing need for computational assistance for error-free, precise detection and rising awareness about importance of early diagnosis of diseases to minimize death rates are key factors fueling global market revenue growth.
Computer Aided Detection (CAD) is a software system that helps in detecting various types of cancers, neurological or cardiovascular disorders using various imaging modalities such as computed tomography, tomosynthesis, and magnetic resonance imaging. It aids in reducing observational oversights, false-negative results, and provides error-free results in minimum time. Rising prevalence of chronic diseases, such as breast cancer, lung cancer, stroke, and neurological dysfunctions, is a primary factor increasing demand for CAD systems. Technological advancements in diagnostic techniques, increasing efforts by government to raise awareness about cancer and treatment, and growing investments by market players to develop advanced products with 3D imaging are significant factors boosting revenue growth.
However, factors, such as unfavorable reimbursement policies, increasing costs associated with CAD tools, and lack of trained professionals to operate systems are major restraining factors expected to affect growth of global computer aided detection market.
Request Brochure for computer aided detection (CAD) market Report
Market Dynamics:
Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.
Surging demands and transition to patient-centric care delivery across geographies will change pharma and healthcare market trends through 2028.
Competitive Outlook:
The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and Machine Learning to enhance efficiency of medical products. Top companies in the market are focusing on R&D activities to expand their product offerings and cater to unmet medical needs.
This report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, and recent developments in both historic and present contexts.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4050
